Anjana Pillai to Bilirubin
This is a "connection" page, showing publications Anjana Pillai has written about Bilirubin.
Connection Strength
0.053
-
Progression patterns and therapeutic sequencing following immune checkpoint inhibition for hepatocellular carcinoma: An international observational study. Liver Int. 2023 03; 43(3):695-707.
Score: 0.053